Last reviewed · How we verify
High-dose ropivacaine
At a glance
| Generic name | High-dose ropivacaine |
|---|---|
| Also known as | MRI scan |
| Sponsor | Yilin Zhao |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty (NA)
- Zynrelef Versus Adductor Canal Block (PHASE4)
- Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Patients Undergoing Radical Mastectomy (PHASE1, PHASE2)
- A Study on TLC590 for Managing Postsurgical Pain (PHASE2)
- Dose-response Study of Spinally Administered Ropivacaine for Caesarean Section in Tall Parturients (NA)
- Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain (NA)
- Regional Anesthesia Techniques in Breast Surgery (NA)
- Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High-dose ropivacaine CI brief — competitive landscape report
- High-dose ropivacaine updates RSS · CI watch RSS
- Yilin Zhao portfolio CI